[Clinical differential indication : Wearables vs implantables].

Klinische Differenzialindikation : Wearables vs. Implantables.
Atrial fibrillation ECG monitoring Electrocardiography Implantable cardiac monitors Long-term ambulatory monitoring Wearable monitors

Journal

Herzschrittmachertherapie & Elektrophysiologie
ISSN: 1435-1544
Titre abrégé: Herzschrittmacherther Elektrophysiol
Pays: Germany
ID NLM: 9425873

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 06 07 2020
accepted: 09 07 2020
pubmed: 12 8 2020
medline: 7 10 2020
entrez: 12 8 2020
Statut: ppublish

Résumé

In order to document arrhythmias, indicated due to symptoms or for prognostic purposes, both invasive and noninvasive possibilities for ECG monitoring are available. The choice of the device for monitoring depends mainly on the frequency of arrhythmias. If they occur less than once a month, long-term monitoring becomes necessary which either continuously monitors the rhythm by an implantable device (implantables) or by wearable systems (wearables) which usually register the ECG discontinuously. Because wearables, e.g. smartphones, are basically ubiquitously available, they may be used for ECG monitoring. This paper comments on the use of implantables and wearables for the detection of atrial fibrillation and the documentation of symptomatic arrhythmias in syncope or palpitations.

Identifiants

pubmed: 32780284
doi: 10.1007/s00399-020-00714-7
pii: 10.1007/s00399-020-00714-7
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

288-291

Auteurs

Thorsten Lewalter (T)

Klinik für Kardiologie und Internistische Intensivmedizin, Peter Osypka Herzzentrum, Internistisches Klinikum München Süd, Am Isarkanal 36, 81379, München, Deutschland. thorsten.lewalter@ikms.de.

Clemens Jilek (C)

Klinik für Kardiologie und Internistische Intensivmedizin, Peter Osypka Herzzentrum, Internistisches Klinikum München Süd, Am Isarkanal 36, 81379, München, Deutschland.

Carsten Israel (C)

Evangelisches Klinikum Bethel, Bielefeld, Deutschland.

Johannes Brachmann (J)

Klinikum Coburg, Coburg, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH